Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program

Japan’s immunization program resumed proactively recommending the use of the human papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this recommendation in June 2013. The promotion of catch-up vaccinations is an urgent issue to reduce the increase in cervical cancer and other c...

Descripción completa

Detalles Bibliográficos
Autor principal: Ujiie, Mugen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
HPV – Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746481/
https://www.ncbi.nlm.nih.gov/pubmed/35767827
http://dx.doi.org/10.1080/21645515.2022.2090777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746481/
https://www.ncbi.nlm.nih.gov/pubmed/35767827
http://dx.doi.org/10.1080/21645515.2022.2090777

Ejemplares similares